A novel tri-layered buccal mucoadhesive patch for drug delivery: Assessment of nicotine delivery

Journal of Pharmacy and Pharmacology

Volumn 63, Issue 6, 2011, Pages 794-799

  Rao, Shasha ^a   Song, Yunmei ^a   Peddie, Frank ^a   Evans, Allan M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

buccal mucoadhesive drug delivery; mucoadhesive patch; nicotine base; nicotine polacrilex; nicotine replacement therapy

Indexed keywords

ADHESIVE AGENT; CALCIUM PHOSPHATE DIBASIC; NICOTINE GUM; NICOTINE PATCH; SODIUM CHLORIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG RELEASE; EX VIVO STUDY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MUCOADHESION; NONHUMAN; PHYSICAL CHEMISTRY; SWINE; TABLET;

ADHESIVES; ADMINISTRATION, BUCCAL; ADMINISTRATION, MUCOSAL; ADSORPTION; ANIMALS; CALCIUM SULFATE; DRUG DELIVERY SYSTEMS; HUMANS; MOUTH; MOUTH MUCOSA; NICOTINE; SWINE; TABLETS; TECHNOLOGY, PHARMACEUTICAL;

EID: 79956188606     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01283.x     Document Type: Article

References (16)

1. Sudhakar Y, et al,. Buccal bioadhesive drug delivery-a promising option for orally less efficient drugs. J Control Release 2006; 114: 15-40. (Pubitemid 44128620)
2. Mitra AK, et al,. Peptides and proteins: buccal absorption. In:, Swarbrick J, Boylan JC, eds. Encyclopedia of Pharmaceutical Technology. New York: Marcel Dekker, 2002: 2081-2095.
3. Salamat-Miller N, et al,. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev 2005; 57: 1666-1691. (Pubitemid 41443474)
4. Nagai T, et al,. Bioadhesive dosage forms for buccal/gingival administration. In:, Lenaerts V, Gurny R, eds. Bioadhesive Drug Delivery Systems. Boca Raton: CRC Press, 1990: 137-152.
5. Guo J-H, Cremer K,. Development of bioadhesive buccal patches. In:, Mathiowitz E, et al., eds. Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Development. New York: Marcel Dekker, 1999: 541-562.
6. Patel VM, et al,. Formulation, evaluation, and comparison of bilayered and multilayered mucoadhesive buccal devices of propranolol hydrochloride. AAPS PharmSciTech 2007; 8: Article 22.
7. Mizrahi B, Domb AJ,. Mucoadhesive polymers for delivery of drugs to the oral cavity. Recent Pat Drug Deliv Formul 2008; 2: 108-119.
8. Nicolazzo JA, et al,. The effect of various in vitro conditions on the permeability characteristics of the buccal mucosa. J Pharm Sci 2003; 92: 2399-2410. (Pubitemid 37484766)
9. Kornitzer M, et al,. Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. Prev Med 1995; 24: 41-47.
10. Blondal T, et al,. Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up. BMJ 1999; 318: 285-289. (Pubitemid 29195135)
11. Bohadana A, et al,. Nicotine inhaler and nicotine patch as a combination therapy for smoking cessation: a randomized, double-blind, placebo-controlled trial. Arch Intern Med 2000; 160: 3128-3134.
12. Zhang JC, et al,. [A review of oral mucoadhesive drug delivery system. Pharm J Chin PLA 2002; 19: 135-137 [in Chinese].
13. Chickering III DE, Mathiowitz E,. Definitions, mechanisms, and theories of bioadhesion. In:, Mathiowitz E, et al., eds. Bioadhesive Drug Delivery Systems: Fundamentals, Novel Approaches, and Development. New York: Marcel Dekker, 1999: 1-10.
14. Mortazavi SA,. An in vitro assessment of mucus/mucoadhesive interactions. Int J Pharm 1995; 124: 173-182.
15. Perez-Marcos B, et al,. Release of propranolol hydrochloride from matrix tablets containing hydroxypropylmethylcellulose K4M and carbopol 974. Int J Pharm 1994; 111: 251-259. (Pubitemid 24292903)
16. Park CR, Munday DL,. Development and evaluation of a biphasic buccal adhesive tablet for nicotine replacement therapy. Int J Pharm 2002; 237: 215-226. (Pubitemid 34326435)